Skip to main content

Animations

MJFF Publications

4991 - 5000 of 9145 Results
Title
Year
  • Year
  • 2021
  • 2020
  • 2025
  • 2026
  • 2025
  • 2012
  • 2018
  • 2024
  • 2024
  • 2020
  • Summary Details
    OPEN
    Title: Common and rare variants in HFE are not associated with Parkinson's disease in Europeans
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.05.019
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Constructing treatment episodes from concomitant medication logs: a prospective observational study
    Journal Name: BMJ Open
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1136/bmjopen-2019-034305
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Identification of small molecule dimethyoxyphenyl piperazine inhibitors of alpha-synuclein fibril growth
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41598-025-17658-y
    Citation Count: 0
  • Summary Details
    OPEN
    Title: VGLUT2 in Parkinson’s disease: an emerging therapeutic target
    Journal Name: Expert Opinion on Therapeutic Targets
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1080/14728222.2026.2619754
    Citation Count: 0
  • Profiling the Braak progression in Parkinson’s disease: a transcriptomics and ML driven identification of progressive biomarker and prognostic ceRNA signature
    2025
    Summary Details
    RESTRICTED
    Title: Profiling the Braak progression in Parkinson’s disease: a transcriptomics and ML driven identification of progressive biomarker and prognostic ceRNA signature
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2025.12.011
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Dysregulated dopamine storage increases the vulnerability to α-synuclein in nigral neurons
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2012.05.012
    Citation Count: 57
  • Summary Details
    RESTRICTED
    Title: Multiple system atrophy and apolipoprotein E
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27297
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Validating new symptom emergence as a patient-centric outcome measure for PD clinical trials
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107118
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Cryogel microcarriers for sustained local delivery of growth factors to the brain
    Journal Name: Journal of Controlled Release
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.jconrel.2024.03.023
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Quantifying Spatiotemporal Gait Parameters with HoloLens in Healthy Adults and People with Parkinson’s Disease: Test-Retest Reliability, Concurrent Validity, and Face Validity
    Journal Name: Sensors
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/s20113216
    Citation Count: 49
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.